Hi gbr,
Nice one! I almost missed your reference to the eye cream in regards to the 'Philosophy Renewed Hope in a Jar eye cream'
The following article also highlights what Global Beauty veteran, Ms Scalamandre thinks about growing the skincare market...
How does Coty management work to retain its fluidity and capitalize on its innovative approach to the marketplace? That’s what a sold-out crowd of hundreds of beauty executives aimed to learn more about as they packed Manhattan’s Harmonie Club for CEW’s Newsmaker Forum event: “Coty Prestige: Accelerating Growth.”
Panelists included Steve Mormoris, senior VP of global marketing, American Fragrances; Jean Mortier, president; Jill Scalamandre, SVP, Philosophy Brand and Coty Prestige Skincare; Marc Rey, president, U.S. and regional VP, North America. Pete Born, WWD’s executive editor of beauty, served as the moderator of the lively discussion.
Defining Innovation
Scalamandre offered an example of finding new ways to communicate with consumers, such as with the untraditional social media marketing they pursued with Philosophy’s Loveswept, “in which the consumers actually ended up doing the marketing...” Scalamandre spoke about Coty’s diversification into skincare. She said that consumers no longer see Coty as strictly a fragrance company... In regard to Philosophy, she said it has always been “a multichannel brand with a lot of emotional benefits....”
Looking Ahead
Promising additional growth also lies with one of Coty’s older portfolio members. When asked about Coty’s Lancaster skincare brand, Scalamandre said it’s still a leader in Europe and an expanding brand in Asia. In fact, she told the crowd, “Lancaster’s suncare technology can be applied to skincare - and could be the brand that bridges the two.” Mormoris conceded that the flattening of the fragrance market, due to fragmentation in general, has put a renewed focus on skincare.
Scalamandre thinks innovation as far as growing the skin care market will come from technology that makes products more effective and absorb better.
Born’s final question: “What will a successful product look like?”
Scalamandre replied, “One that has a million people talking about it.”
Coty's Leadership Team shares its Strategies
In regards to OBJ bouncing between the names of 'Coty' and 'Philosophy' on a number of occasions leading to the speculation that OBJ may already be working with more than one of Coty's business franchises, the announcement made back in May last year also appears to be alluding to this possibility. Ironically, OBJ actually omitted the names of both Coty and Philosophy in this release, but was not shy about making inference to partner scientific teams in both the USA and Europe
02/05/2013
The clinical trial units were developed by the Company in consultation with its partner’s scientific teams in the USA and Europe and will be evaluated in an independent clinical efficacy study in the USA.
eSkin™ incorporates OBJ’s patented Dermaportation powered transdermal delivery technology that has been shown to enhance the delivery of key anti‐aging and skincare ingredients deeper and more effectively into the skin.
If successful the clinical trial will be a major step forward for the Company in the potential commercial development of its powered drug delivery technology and its web‐enabled personalisation capabilities that allow eSkin™ to optimise cosmetic delivery precisely to individual needs via the world wide web using portable devices.
In terms of the 'mnemonic' profiles that you referenced in your previous post, the above paragraph or following slogan probably defines the meaning in somewhat more laymen terms for us...
Personalize your skincare!
everywhere, every need, every skin, every day
- Forums
- ASX - By Stock
- WFL
- Ann: COTY Set to License OBJ's Powered Technology
Ann: COTY Set to License OBJ's Powered Technology, page-159
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online